Sanofi Inks $1.9B Pharma Acquisition Deal with Kadmon Holdings
Sanofi recently entered into a $1.9 billion pharma acquisition deal with Kadmon Holdings to strengthen the growth of its transplant business. Under the terms of the agreement, Sanofi will continue to...3 Use Cases for Real World Evidence in Pharma Drug Development
Real world evidence (RWE) in pharmaceutical drug development analyzes real world data, such as electronic health records and data from wearable devices, to complement clinical trials data. RWE...Pharmaceutical Supply Chain Needs Reform for Transparency, Access
The US pharmaceutical supply chain must be remodeled to address long-standing conflicts and achieve a delivery model marked by transparency, affordability, and access to care, according to an expert...Biden Pushes Policy Changes to Protect Pharmaceutical Supply Chain
The White House, the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), and FDA recently released policy recommendations to protect US pharmaceutical supply chains. The...Pharmaceutical Supply Chain Cybersecurity Risk Tops $31M Annually
Ransomware susceptibility for pharmaceutical manufacture supply chain tops $31 million annually, according to new research from Black Kite. Black Kite’s 2021 Ransomware Risk Pulse:...FDA Approves G1’s Cosela to Prevent Damage from Chemotherapy
FDA recently approved G1 Therapeutics’ Cosela a therapy intended to reduce the frequency of chemotherapy-induced bone marrow suppression in adults for extensive-stage small-cell lung...Sponsored by Pure Storage
